More Business Wire
View Older Stories View Newer Stories-
Pacific Avenue Capital Partners Establishes Paris France Office and Xavier Lambert Joins as Head of Europe to Lead Firm’s EU Expansion
-
Hamilton Global Opportunities plc (ALHGO.PA) Announces the Successful Issuance of Senior Notes With a Maturity of 2 Years.
-
Media Release: Allianz lifts financial ambitions at its Capital Markets Day 2024
-
Dassault Systèmes and UniLaSalle Combine Learning and Exploring with Virtual Worlds in New 3DEXPERIENCE Edu Center of Excellence
-
onsemi to Acquire Silicon Carbide JFET Technology to Enhance Its Power Portfolio for AI Data Centers
-
Sirius Therapeutics Announces Promising Phase I Clinical Data from Its Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders
-
CORRECTING and REPLACING PHOTO Clari Named to Deloitte Technology Fast 500™, Recognized as One of North America’s Fastest-Growing Technology Companies
-
Following Presentation at UBS Global Media and Communications Conference, T-Mobile Reiterates Positive Growth Momentum
-
Mori Memorial Foundation Issues GPCI–2024 and GPCI–Financial Centers Reports:
-
Health Canada approves Celltrion’s Omlyclo™ (CT-P39), the first and only omalizumab biosimilar in Canada
-
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
-
BrainChip Awarded Air Force Research Laboratory Radar Development Contract
-
CORRECTING and REPLACING: MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH 2024 Annual Meeting
-
SOPA 2025 Journalism Awards Open for Entries; Deadline Feb. 13
-
AIG Closes Sale of 21.6% Ownership Stake of Corebridge to Nippon Life
-
Material Receives Splash Award for Outstanding Drupal Website
-
Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies
-
Lomiko Metals Announces Management Transition and Update on the 2024 Annual General Meeting Materials Amid Canada Post Strike
-
New and Updated Data for Genentech’s Fixed-Duration Columvi and Lunsumio at ASH 2024 Reinforce Their Potential to Improve Outcomes for People With Lymphoma
-
Immune-Onc Therapeutics Presents Updated Data from Phase 1b Study of IO-202 Highlighting Promising Efficacy and Safety Data in CMML Patients at 2024 American Society of Hematology (ASH) Annual Meeting
-
AMCON Distributing Company Acquires Arrowrock Supply
-
MP Materials Announces Exchanges of a Portion of its 0.25% Green Convertible Senior Notes due 2026, Representing a Net Reduction of $25 Million of Outstanding Indebtedness
-
AKA Identity Unveils Early Access Program for its Transformative AI-Native Identity Management Platform
-
Family of Teen Who Died During Routine Wisdom Teeth Removal Files Lawsuit Against Oral Surgeon and Clinic, According to Luvera Law Firm
-
Jackson Acquisition Company II Announces Pricing of $200 Million Initial Public Offering
-
Upper Fillmore Revitalization Project and La Méditerranée Sign Lease Extension
-
ATSG Announces Expiration of “Go-Shop” Period
-
MAIA Biotechnology Announces Private Placement of Approximately $950,000
-
Otter Tail Power Company Advances Plans to Add 345 Megawatts of Solar
-
Walker & Dunlop Arranges 2nd Largest Sale in San Diego in 2024
-
Landcar Casualty Company Receives Upgraded Credit Rating from AM Best
-
JPMorganChase Declares Common Stock Dividend
-
California American Water Proudly Recognizes Partnership with The Greater Sacramento Urban League
-
Central Garden & Pet to Participate in KeyBanc Capital Markets’ Virtual December Consumer Spotlight
-
Compass Minerals Announces Conference Call to Discuss Fourth-Quarter and Fiscal 2024 Results
-
Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline
-
Kite’s Yescarta® Only CAR T-Cell Therapy to Show Durable Response and Long-Term Survival After Five Years in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas at ASH 2024
-
Electra Therapeutics Presents Positive Clinical Results From Completed Phase 1b Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) in an Oral Session at ASH 2024
-
Capstone Copper Publishes 2023 Sustainability Report
-
CHS Owners Elect Five Board Members
-
Hess Midstream LP Publishes Sustainability Report
-
Vecima Announces Cost Restructuring, Sharpening Focus on Profitable Growth
-
Momentus Inc. Announces Reverse Stock Split
-
ComEd and Ameresco Complete Community Solar Project at Former Landfill in Belvidere
-
Pembina Pipeline Corporation Announces Redemption of Series 22 Preferred Shares
-
Thunderbird Entertainment Group Announces Arrangements to Address Mailing Delays Resulting from Canada Post Strike
-
DNP Select Income Fund Inc. Section 19(a) Notice
-
Hamilton ETFs Wins Two LSEG Lipper Fund Awards for 2024
-
Trustar Bank Announces Branch Relocation in Great Falls, VA
-
Psycho Bunny Chooses Quebec City for Its 100th Store
